May 30, 2016
Recommended Topic Related To:

Omniscan

"Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.

Patients with LAL deficiency (also known as Wolman disea"...

A A A

Omniscan

Overdosage
Contraindications

OVERDOSE

Clinical consequences of overdose with OMNISCAN have not been reported. The minimum lethal dose of intravenously administered OMNISCAN in rats and mice is greater than 20 mmol/kg (200 times the recommended human dose of 0.1 mmol/kg; 67 times the cumulative 0.3 mmol/kg dose). OMNISCAN is dialyzable.

CONTRAINDICATIONS

OMNISCAN is contraindicated in patients with:

  • chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
  • acute kidney injury
  • prior hypersensitivity reaction to OMNISCAN
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/5/2014

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.